1-4 of 4
Yusuke Ito
Close
Sort by
Journal Articles

Novel Cancer Immunotherapy Using Cell-Derived Membrane Vesicles Orchestrates Multimodal Antitumor Immunity

Yusuke Ito, Seiichi Ohta, Yuki Kagoya
Journal: Blood
Blood (2023) 142 (Supplement 1): 353.
https://doi.org/10.1182/blood-2023-179748
Published: 2023
Journal Articles

Efficient production of human neutrophils from iPSCs that prevent murine lethal infection with immune cell recruitment

Masashi Miyauchi, Yusuke Ito, Fumio Nakahara, Toshiya Hino, Fumi Nakamura, Yuki Iwasaki, Taiki Kawagoshi, Junji Koya, Akihide Yoshimi, Shunya Arai, Yuki Kagoya, Mineo Kurokawa
Journal: Blood
Blood (2021) 138 (24): 2555–2569.
https://doi.org/10.1182/blood.2021011576
Published: 2021
Includes: Supplemental data
Journal Articles

CD62L Expression Level Dictates the Cell Fate of Myeloid Progenitors in Mice and Humans

Yusuke Ito, MD, Fumio Nakahara, MD PhD, Yuki Kagoya, MD PhD, Mineo Kurokawa, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–27.
https://doi.org/10.1182/blood-2020-134753
Published: 2020
Journal Articles

Genetically Engineered Hematopoietic Progenitors Derived from Human Induced Pluripotent Stem Cells Achieve the Feeder-Free and Robust Production of Neutrophils with the Functional Capacity In Vivo

Masashi Miyauchi, Yusuke ITO, MD, Fumio Nakahara, MD PhD, Fumi Nakamura, MD PhD, Yuki Iwasaki, Taiki Kawagoshi, Yuki Kagoya, MD PhD, Shunya Arai, MD PhD, Mineo Kurokawa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 720.
https://doi.org/10.1182/blood-2019-126348
Published: 2019